Related Experiment Video
Updated: Aug 8, 2026

A Multi-detection Assay for Malaria Transmitting Mosquitoes
Published on: February 28, 2015
[Recombination and cloning of MSP1(19) and PfCMR of Plasmodium falciparum]
1Department of Parasitology, Sun Yat-sen University of Medical Sciences, Guangzhou 510089.
Aim:
To construct a recombinant plasmid DNA encoding multiantigens of Plasmodium falciparum and to provide the requirements for DNA immunization.
Methods:
Two oligonucleotide primers were designed to amplify MSP1(19), the purified PCR products were digested by Sal I + Xba I, and the recombinant plasmid pWR450-1/PfCMR was digested by EcoR I + Sal I to recover PfCMR gene. PfCMR and MSP1(19) gene fragments were linked and recombined with mammalian expression vector pcDNA3.
Results:
The MSP1(19) gene fragment with about 363 base pairs were specifically amplified by using PCR technique. The positive recombinant pcDNA3-PfCMR-MSP1(19) (named pcDNA3-Pf8) was screened and identified by agarose gel electrophoresis, endonulease digestion and PCR technique, the whole length of Pf8 is 618 bp.
Conclusion:
By specifically amplifying MSP1(19) gene at the C-terminal of MSP1, a recombinant plasmid pcDNA3-Pf8 encoding multiantigens of Plasmodium falciparum was successfully constructed.
Insights
A novel recombinant plasmid, pcDNA3-Pf8, encoding multiple Plasmodium falciparum antigens was successfully constructed. This advancement supports the development of DNA vaccines against malaria.
Area of Science:
- Molecular Biology
- Immunology
- Parasitology
Context:
- Malaria remains a significant global health challenge, necessitating innovative vaccine strategies.
- Plasmodium falciparum is the deadliest malaria parasite species.
- Effective vaccines require antigens that elicit robust immune responses.
Purpose:
- To construct a recombinant plasmid DNA encoding multiantigens of Plasmodium falciparum.
- To establish requirements for DNA immunization against malaria.
Summary:
- The study amplified the MSP1(19) gene fragment using PCR and cloned it with the PfCMR gene into the pcDNA3 vector.
- The resulting recombinant plasmid, pcDNA3-Pf8, was confirmed through agarose gel electrophoresis, endonuclease digestion, and PCR.
- This construct encodes multiple Plasmodium falciparum antigens, specifically targeting the C-terminal of MSP1.
Impact:
- Successful construction of a multiantigen DNA vaccine candidate for Plasmodium falciparum.
- Provides a foundation for further research and development of DNA-based malaria vaccines.
- Contributes to the ongoing efforts to control and eradicate malaria globally.
More Related Videos
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Related Concept Videos
Viral Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Malaria